Effect of Metallic Nanoparticles on Nosocomial Bacteria

NCT04775238 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-03-03

No results posted yet for this study

Summary

This research aims to study the properties of metallic nanoparticles"MNPs" (silver nanoparticles "AgNps" and copper nanoparticles "CuNps") on the 2 most common nosocomial bacteria which are highly resistant to antibiotics including Staphylococcus aureus and Pseudomonas aeruginosa, to evaluate the growth inhibiting properties of MNPs on all bacterial isolates, to evaluate the biofilm inhibitory effect on biofilm forming bacterial isolates and the synergistic effect of these MNPs in combination with antibiotics on the antibiotic resistant isolates.

Conditions

  • Nosocomial Infections

Interventions

OTHER

Silver nanoparticles

AgNPs (19±5 nm)

OTHER

Copper nanoparticles

CuNPs (150-350 nm)

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Nahed Fathallah, lecturer · Sohag University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-27
Primary Completion
2021-06-20
Completion
2021-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04775238 on ClinicalTrials.gov